SNDL
SNDL, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.41
+4.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 47.38x
- P/S forward
- 0.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.47x
- Price / sales
- 0.52x
- Price / cash flow
- 9.46x
Enterprise value
- Enterprise value
- $358.5M
- EV / sales
- 0.55x
- EV / EBITDA
- 11.39x
- EV / EBIT
- -52.03x
- Market cap
- $343.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026